1st Circ. Gauges Antitrust Immunity In Enoxaparin Row

A three-judge First Circuit panel Thursday grilled opposing counsel on what exactly caused the injuries Amphastar alleged in a suit against rival Momenta over generic anticoagulant enoxaparin, and on whether Momenta...

Already a subscriber? Click here to view full article